RxDoctor Payments Data

Mahmoud Malas, MD

Vascular Surgery · la Jolla, CANPI 1013953892

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (27.1%), travel and lodging and grants — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Cordis US CORP. at 39.6% of the total. Among vascular surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$124,187in general payments, 2019–2025

Across 259 payments — averaging $479.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cordis US CORP.$49K
  • Medtronic$22K
  • Silk Road Medical, Inc.$19K
  • Bard Peripheral Vascular, Inc.$11K
  • Artegraft Inc.$7K
  • W. L. Gore & Associates, Inc.$4K
  • plus $12K from 17 others
$383,519in research payments, 2019–2025

Across 30 payments — averaging $12,784 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$212K
  • Silk Road Medical, Inc.$67K
  • Endologix LLC$62K
  • Medtronic$18K
  • Humacyte Global, Inc.$16K
  • Bolton Medical Inc$8K

What the payments were for

  • Consulting fees$33,60027%
  • Speaking & faculty fees$17,05014%
  • Grants$21,00017%
  • Travel & lodging$26,36621%
  • Food & beverage$14,58512%
  • Education$11,5879%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$124,187 in reported general payments places this provider in the 95th percentile of 519 vascular surgery providers in California.

See all vascular surgery providers in California

Medicare billing

Part B allowed, 2024
$177,785
Medicare patients
555
Services billed
2,276

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other vascular surgery in la Jolla

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →